Learn about the disease, illness and/or condition Malignant Hyperpyrexia (Malignant Hyperthermia) including: symptoms, causes, treatments, contraindications and conditions at ClusterMed.info.
Malignant Hyperpyrexia (Malignant Hyperthermia)
|Malignant Hyperpyrexia (Malignant Hyperthermia)
Malignant Hyperpyrexia (Malignant Hyperthermia) Information
Malignant hyperthermia facts*
*Malignant hyperthermia facts medical author: Melissa Conrad Stoppler, MD
How common is malignant hyperthermia?
Malignant hyperthermia occurs in 1 in 5,000 to 50,000 instances in which people are given anesthetic gases. Susceptibility to malignant hyperthermia is probably more frequent, because many people with an increased risk of this condition are never exposed to drugs that trigger a reaction.
How do people inherit malignant hyperthermia?
Malignant hyperthermia susceptibility is inherited in an autosomal dominant pattern, which means one copy of the altered gene in each cell is sufficient to increase the risk of a severe reaction to certain drugs used during surgery. In most cases, an affected person inherits the altered gene from a parent who is also at risk for the condition.
What genes are related to malignant hyperthermia?
Variations of the CACNA1S and RYR1 genes increase the risk of developing malignant hyperthermia. Researchers have described at least six forms of malignant hyperthermia susceptibility, which are caused by mutations in different genes. Mutations in the RYR1 gene are responsible for a form of the condition known as MHS1. These mutations account for most cases of malignant hyperthermia susceptibility. Another form of the condition, MHS5, results from mutations in the CACNA1S gene. These mutations are less common, causing less than 1 percent of all cases of malignant hyperthermia susceptibility. The RYR1 and CACNA1S genes provide instructions for making proteins that play essential roles in muscles used for movement (skeletal muscles). For the body to move normally, these muscles must tense (contract) and relax in a coordinated way. Muscle contractions are triggered by the flow of certain charged atoms (ions) into muscle cells. The proteins produced from the RYR1 and CACNA1S genes are involved in the movement of calcium ions within muscle cells. In response to certain signals, the CACNA1S protein helps activate the RYR1 channel, which releases stored calcium ions within muscle cells. The resulting increase in calcium ion concentration inside muscle cells stimulates muscle fibers to contract. Mutations in the RYR1 or CACNA1S gene cause the RYR1 channel to open more easily and close more slowly in response to certain drugs. As a result, large amounts of calcium ions are released from storage within muscle cells. An overabundance of available calcium ions causes skeletal muscles to contract abnormally, which leads to muscle rigidity in people with malignant hyperthermia. An increase in calcium ion concentration within muscle cells also activates processes that generate heat (leading to increased body temperature) and produce excess acid (leading to acidosis). The genetic causes of several other types of malignant hyperthermia (MHS2, MHS4, and MHS6) are still under study. A form of the condition known as MHS3 has been linked to the CACNA2D1 gene. This gene provides instructions for making a protein that plays an essential role in activating the RYR1 channel to release calcium ions into muscle cells. Although this gene is thought to be related to malignant hyperthermia in a few families, no causative mutations have been identified.
What is malignant hyperthermia?
Malignant hyperthermia is a severe reaction to particular drugs that are often used during surgery and other invasive procedures. Specifically, this reaction occurs in response to some anesthetic gases, which are used to block the sensation of pain, and with a muscle relaxant that is used to temporarily paralyze a person during a surgical procedure. If given these drugs, people at risk for malignant hyperthermia may experience muscle rigidity, breakdown of muscle fibers (rhabdomyolysis), a high fever, increased acid levels in the blood and other tissues (acidosis), and a rapid heart rate. Without prompt treatment, the complications of malignant hyperthermia can be life-threatening. People at increased risk for this disorder are said to have malignant hyperthermia susceptibility. Affected individuals may never know they have the condition unless they undergo testing or have a severe reaction to anesthesia during a surgical procedure. While this condition often occurs in people without other serious medical problems, certain inherited muscle diseases (including central core disease and multiminicore disease) are associated with malignant hyperthermia susceptibility.
What other names do people use for malignant hyperthermia?
Where can I find information about diagnosis, management, or treatment of malignant hyperthermia?
These resources address the diagnosis or management of malignant hyperthermia and may include treatment providers.
Diseases & Illnesses Definitions Of The Day
- Salivary Gland Cancer ‐ How does salivary gland cancer spread in the body?, How does staging affect treatment options? …
- Excessive Daytime Sleepiness (Narcolepsy) ‐ Can narcolepsy be cured?, For more information on narcolepsy …
- Gas (Intestinal Gas (Belching, Bloating, Flatulence)) ‐ How are the causes of belching, bloating/distention, and flatulence evaluated? …
- Canker Sores ‐
- Stuttering ‐ How is speech normally produced?, How is stuttering diagnosed? …
- Tooth Damage (Dental Injuries) ‐ Dental injury facts, How is a fracture of the enamel and dentin treated? …
- Children, Autism (Autism and Communication) ‐ Autism facts, Behaviors, Can diet and supplements play a role in the treatment of autism? …
- Excision Breast Biopsy (Breast Biopsy) ‐ Breast biopsy facts, How does a health care professional confirm the presence of a breast growth? …
- Eczema Facts ‐ Are there different types of eczema? What causes and risk factors of eczema? …
- Pain, Cancer (Cancer Pain) ‐ How Else Can Cancer Pain Be Treated?, Introduction, What Are the Symptoms of Cancer Pain? …